Suvretta Capital Management logo

Suvretta Capital Management

North America, New York, United States, New York

Description

Suvretta Capital Management is an investment management company.

Investor Profile

Suvretta Capital Management has backed more than 28 startups, with 2 new investments in the last 12 months alone. The firm has led 6 rounds, about 21% of its total and boasts 17 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series C, Series A rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, China.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 2 rounds in the past year.

Stage Focus

  • Post Ipo Equity (64%)
  • Series C (11%)
  • Series A (7%)
  • Series B (4%)
  • Series Unknown (4%)
  • Series D (4%)
  • Private Equity (4%)
  • Convertible Note (4%)

Country Focus

  • United States (82%)
  • United Kingdom (7%)
  • China (4%)
  • Switzerland (4%)
  • Sweden (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Therapeutics
  • Pharmaceutical
  • Genetics
  • Health Diagnostics
  • Life Science
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Suvretta Capital Management frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 5
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 5
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 9
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 5
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 4
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 4

What are some of recent deals done by Suvretta Capital Management?

Avalyn Pharma

Seattle, Washington, United States

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

BiopharmaBiotechnologyMedicalPharmaceutical
Series DJul 22, 2025
Amount Raised: $100,000,000
Benitec Ltd

Hayward, California, United States

Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.

BiotechnologyGeneticsHealth DiagnosticsMedicalTherapeutics
Post Ipo EquityMar 25, 2025
Amount Raised: $30,000,000
VeraDermics

New Haven, Connecticut, United States

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.

Health CarePharmaceuticalTherapeutics
Series BDec 11, 2024
Amount Raised: $75,000,000
Abeona Therapeutics

New York, New York, United States

Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.

BiotechnologyGeneticsHealth CareManufacturingMedical Device
Post Ipo EquityMay 3, 2024
Amount Raised: $75,000,000
Zura Bio

San Diego, California, United States

Zura Bio is a clinical-stage biotechnology company that develops medicines for immune system disorders.

BiopharmaBiotechnologyMedical
Post Ipo EquityApr 18, 2024
Amount Raised: $112,500,000
Benitec Ltd

Hayward, California, United States

Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.

BiotechnologyGeneticsHealth DiagnosticsMedicalTherapeutics
Post Ipo EquityApr 18, 2024
Amount Raised: $40,000,000
Fate Therapeutics

La Jolla, California, United States

Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 19, 2024
Amount Raised: $100,000,000
Pepgen

Oxford, Oxfordshire, United Kingdom

PepGen is empowering nucleic acid therapeutics to go the distance.

BiotechnologyClinical TrialsMedical
Post Ipo EquityFeb 7, 2024
Amount Raised: $80,100,000
Kura Oncology

La Jolla, California, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

BiopharmaBiotechnologyGeneticsHealth CareMedicalOncologyPrecision Medicine
Post Ipo EquityJan 24, 2024
Amount Raised: $150,000,000
Benitec Ltd

Hayward, California, United States

Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases.

BiotechnologyGeneticsHealth DiagnosticsMedicalTherapeutics
Post Ipo EquityAug 11, 2023
Amount Raised: $3,000,000